STAT3 determines IL-4 signalling outcomes in naïve T cells
| dc.contributor.author | Deimel, Lachlan | |
| dc.contributor.author | Li, Zheyi | |
| dc.contributor.author | Roy, Sreeja | |
| dc.contributor.author | Ranasinghe, Charani | |
| dc.date.accessioned | 2022-06-23T22:35:00Z | |
| dc.date.available | 2022-06-23T22:35:00Z | |
| dc.date.issued | 2021-05-18 | |
| dc.date.updated | 2021-05-23T10:06:27Z | |
| dc.description.abstract | IL-4 production is associated with low-avidity, poorly cytotoxic T cell induction that contributes to viral immune evasion and the failure of T cell-based vaccines. Yet, the precise mechanisms that regulate IL-4 signalling in T cells remain elusive. Mounting evidence indicates that cells can dynamically alter their IL-4/IL-13 receptor signature to modulate downstream immune outcomes upon pathogen encounter. Here, we describe how naïve (CD62L+CD44lo–mid) CD4 and CD8 T cells distinctly engage both STAT6 and STAT3 in response to IL-4. We further show that IL-4R⍺ expression is both time- and IL-4 concentration-dependent. Remarkably, our findings reveal that STAT3 inhibition can ablate IL-4R⍺ and affect transcriptional expression of other Stat and Jak family members. By extension, the loss of STAT3 lead to aberrant STAT6 phosphorylation, revealing an inter-regulatory relationship between the two transcription factors. Moreover, IL-4 stimulation down-regulated TGF-β1 and IFN-γR1 expression on naïve T cells, possibly signifying the broad regulatory implications of IL-4 in conditioning lineage commitment decisions during early infection. Surprisingly, naïve T cells were unresponsive to IL-13 stimulation, unlike dendritic cells. Collectively, these findings could be exploited to inform more efficacious vaccines, as well as design treatments against IL-4/IL-13-associated disease conditions. | en_AU |
| dc.format.mimetype | application/pdf | en_AU |
| dc.identifier.issn | 2045-2322 | en_AU |
| dc.identifier.uri | http://hdl.handle.net/1885/267562 | |
| dc.language.iso | en_AU | en_AU |
| dc.provenance | This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. | en_AU |
| dc.publisher | Nature Publishing Group UK | en_AU |
| dc.relation | http://purl.org/au-research/grants/nhmrc/APP1136351 | en_AU |
| dc.rights | © 2021 The authors | en_AU |
| dc.rights.license | Creative Commons Attribution licence | en_AU |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en_AU |
| dc.source | Scientific Reports | en_AU |
| dc.title | STAT3 determines IL-4 signalling outcomes in naïve T cells | en_AU |
| dc.type | Journal article | en_AU |
| dcterms.accessRights | Open Access | en_AU |
| local.bibliographicCitation.issue | 1 | en_AU |
| local.contributor.affiliation | Deimel, Lachlan P., Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University | en_AU |
| local.contributor.affiliation | Li, Zheyi, Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University | en_AU |
| local.contributor.affiliation | Roy, Sreeja, Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University | en_AU |
| local.contributor.affiliation | Ranasinghe, Charani, Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University | en_AU |
| local.contributor.authoruid | u4107621 | en_AU |
| local.description.notes | Imported from Springer Nature | en_AU |
| local.identifier.ariespublication | a383154xPUB19148 | |
| local.identifier.citationvolume | 11 | en_AU |
| local.identifier.doi | 10.1038/s41598-021-89860-7 | en_AU |
| local.publisher.url | https://www.nature.com/ | en_AU |
| local.type.status | Submitted Version | en_AU |
Downloads
Original bundle
1 - 1 of 1
Loading...
- Name:
- STAT3 s41598-021-89860-7.pdf
- Size:
- 6.52 MB
- Format:
- Adobe Portable Document Format
- Description: